January 10, 2011 - Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary
June 30, 2011 - Astellas' Prosidion Subsidary Sells Dipeptidyl Peptidase IV (DPP-IV) Patent Estate and Associated Royalty Interest to Royalty Pharma for USD 609 Million
September 19, 2011 - Aestus Therapeutics and Prosidion Ltd Sign License Agreement for Novel Chronic Pain Therapeutic
December 21, 2011 - AstraZeneca Enters into Option Agreement to Acquire New Class of Diabetes Assets from Prosidion
